共 9 条
[1]
Scandinavian Simvastatin Survival Group.Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Group(4S). The Lancet . 1995
[2]
Scandinavian Simvatatin Survival Group.Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease:the Scandinavian Simvastatin Survival Study(4S). The Lancet . 1994
[3]
Goldbourt U,Behar S,Reiss H,et al.Rationale and design of a secondary prevention trial of increasing serum high -density lipoprotein chelesterol and reducing triglycerides in patients with clinical manifest atheroselerotie heart disease (the Bezafibrate In-faretion prevention Trial). The American Journal of Cardiology . 1993
[4]
Heinonen OP,Huttunen JK.Mannineu V.et al.The Helsinki Heart Study.Coronary heart disease incidence during an extended folloow-up. Journal of Internal Medicine . 1994
[5]
Assmann G,Schulte H.Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease(the PROCAM experience). The American Journal of Cardiology . 1992
[6]
Atherosclerosis[P]. DONG CHUNMING;GOLDSCHMIDT PASCAL J.中国专利:US2008095751A1,2008-04-24
[7]
MAAS investigators.Effect of simvastatin on coronary atheroma:the Multicentre Anti-Atheroma Study (MAAS). The Lancet . 1994
[8]
Blankenhorn DH.Coronary angiographic changes with lovastatin therapy.The Monitored Atherosclerosis Rcgression Study(MARS). Annals of Internal Medicine . 1993
[9]
Waters D,Higginson L,Gladstone P,et al.Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography.The Canadian Coronary Atherosclerosis Intervention Trial. Circulation . 1994